Health effects of using cannabis for therapeutic purposes: A gender analysis of users' perspectives

Substance Use and Misuse

Volumn 46, Issue 6, 2011, Pages 769-780

  Bottorff, Joan L ^a   Bissell, Laura J L ^a   Balneaves, Lynda G ^b   Oliffe, John L ^b   Kang, H Bindy K ^b   Capler, N Rielle ^c   Buxton, Jane A ^b   O'Brien, Robin K ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HEALTH CANADA   (Canada)

Author keywords

cannabis; gender influences; health benefits; medical marijuana; perceived risks

Indexed keywords

CANNABIS;

ADULT; ARTICLE; ATTITUDE TO HEALTH; DRUG USE; FEMALE; HUMAN; MALE; MIDDLE AGED; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; SELF MEDICATION; SEXUAL DEVELOPMENT;

ADULT; ATTITUDE TO HEALTH; CANNABIS; DRUG USERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; SELF MEDICATION; SEX CHARACTERISTICS;

EID: 79953905562     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.537732     Document Type: Review

References (66)

1. Amar, M. B. (2006). Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology, 105, 1-25.
2. Aryana, A., & Williams, M. A. (2007). Marijuana as a trigger for cardiac events: Speculation or scientific certainty. International Journal of Cardiology, 118(2), 141-144. (Pubitemid 46601644)
3. Ashton, C. H., Moore, P. B., Gallagher, P., & Young, A. H. (2005). Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential. Journal of Psychopharmacology, 19(3), 293-300. (Pubitemid 40694948)
4. Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., et al. (1995). Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain & Symptom Management, 10, 89-97.
5. Belle-Isle, L., & Hathaway, A. (2007). Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care, 19(4), 500-506. (Pubitemid 46598747)
6. Bird, C. E., & Rieker, P. P. (1999). Gender matters: An integrated model for understanding men's and women's health. Social Science and Medicine, 48(6), 745-755. (Pubitemid 29089260)
7. Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006). Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Reumatology, 45, 50-52. (Pubitemid 43033874)
8. Braitstein, P., Kendall, T., Chan, K., Wood, E., Montaner, J. S. G., O'Shaughnessy, et al. (2001). Mary Jane and her patients: Sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS, 15(4), 532-533. (Pubitemid 32207577)
9. Branney, P., & White, A. (2008). Big boys don't cry: Depression and men. Advances in Psychiatric Treatment, 14, 256-262.
10. Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967-1977. (Pubitemid 39441395)
11. Butters, J. E. (2004). The impact of peers and social disapproval on high-risk cannabis use: Gender differences and implications for drug education. Drugs: Education, Prevention, and Policy, 11(5), 381-390. (Pubitemid 39508359)
12. Canadian Medical Protective Association. (2001). Marijuana for medical reasons-The medical declaration form: An article for physicians by physicians. Retrieved April 2, 2010, from the World Wide Web: https://www.cmpaacpm.ca/ cmpapd04 /docs/resource files/infosheets/2009/com is09103-e.cfm
13. Capler, R., & Lucas, P. (2006). Guidelines for the community-based distribution of medical cannabis in Canada. British Columbia Compassion Club Society and Vancouver Island Compassion Society. Retrieved August 20, 2009, from theWorldWideWeb: http://thevics.com/PDF/medcan guidelines.pdf
14. Charmaz, K. (1995). Identity, dilemmas of chronically ill men. In D. Sabo & D. F. Gordon (Eds.), Men's health and illness: Gender, power and the body (pp. 269-288). Thousand Oaks, CA: Sage Publications.
15. Clark, A. J., Ware, M., Yazer, E., Murray, T. J., & Lynch, M. E. (2003). Patterns of cannabis use among patients with multiple sclerosis. Neurology, 62, 2098-2100.
16. Coggans, N., Dalgarno, P., Johnson, L., & Shewan, D. (2004). Long-term heavy cannabis use: Implications for health education. Drugs: Education, Prevention, and Policy, 11(4), 299-313. (Pubitemid 39203290)
17. College of Physicians and Surgeons of British Columbia. (2009). Resource manual-Marijuana for medical purposes. Retrieved February 15, 2010, from the World Wide Web: https://www .cpsbc.ca/files/u6/Marijuana-for-Medical-Purposes. pdf
18. Coomber, R., Oliver, M., & Morris, C. (2003). Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues, 33, 325-356. (Pubitemid 36830687)
19. Courtenay, W. H. (2000). Constructions of masculinity and their influence on men's well-being: A theory of gender and health.Social Science and Medicine, 50, 1385-1401. (Pubitemid 30100386)
20. Croxford, J. L. (2003). Therapeutic potential of cannabinoids in CNS disease. CNS Drugs, 17(3), 179-202. (Pubitemid 36286534)
21. Degenhardt, L., Hall, W., & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71(1), 37-48. (Pubitemid 36734857)
22. de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R., & Israelski, D. M. (2005). Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. Journal of Acquired Immune Deficiency Syndrome, 38(1), 43-46. (Pubitemid 40094117)
23. Eubanks, L. M., Rogers, C. J., Beuscher, A. E., Koob, G. F., Olson, A. J.,Dickerson, T. J., et al. (2006).Amolecular link between the active component of marijuana and Alzheimer's disease pathology.Molecular Pharmaceutics, 3(6), 773-777. (Pubitemid 46087493)
24. Fischer, B., Reimer, J., Firestone, M., Kalousek, K., Rehm, J., & Heathcote, J. (2006). Treatment for hepatitis C virus and cannabis use in illicit drug user patients: Implications and questions.European Journal of Gastroenterology & Hepatology, 18,1039-1042. (Pubitemid 44379354)
25. Furler, M. D., Einarson, T. R., Millson, M., Walmsley, S., & Bendayan, R. (2004). Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care and STDs, 18(4), 215-228. (Pubitemid 38558998)
26. Galdas, P. M., Cheater, F., & Marshall, P. (2005). Men and health help-seeking behaviour: Literature review. Journal of Advanced Nursing, 49, 616-623. (Pubitemid 40417364)
27. Hall, W., Degenhardt, L., & Teesson, M. (2004). Cannabis use and psychotic disorders: An update. Drug and Alcohol Review, 23,433-443. (Pubitemid 40019751)
28. Harris, D., Jones, R. T., Shank, R., Nath, R., Fernandez, E., Goldstein, K., et al. (2000). Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases, 19(3), 89-103.
29. Health Canada. (2003). Information for health care professionals (revised)-Marihuana. Retrieved February 15, 2010, from the World Wide Web: http://www.hc-sc.gc.ca/dhp-mps/alt formats /hecs-sesc/pdf/marihuana/how-comment/ medpract/infoprof/marihuana- eng.pdf
30. Health Canada. (2005). Fact sheet-Medical access to marihuana. Retrieved February 15, 2010, from the World Wide Web:http://www.hc-sc.gc.ca/dhp-mps/ marihuana/law-loi/fact sheetinfofiche-eng.php
31. Health Canada. (2010). Health Canada statement on medical marihuana compassion clubs. Ottawa, ON: Health Canada. Retrieved July 13, 2010, from the World Wide Web: http://www.library.cornell.edu/resrch/citmanage/apa
32. Howard, J., Kofi, A. A., Holdcroft, A., Korn, S., & Davies, S. C. (2005). Cannabis use in sickle cell disease: A questionnaire study. British Journal of Haematology, 131, 123-128. (Pubitemid 43899717)
33. Howson, R. (2006). Challenging hegemonic masculinity. London, NY: Routledge.
34. Johnson, J.,Greaves, L.,&Repta, R. (2009). Better science with sex and gender: Facilitating the use of a sex and gender-based analysis in health research. International Journal for Equity in Health, 8(14). Retrieved June 15, 2010, from the World Wide Web: http://www.equityhealthj.com/content/pdf/1475- 9276-8-14.pdf
35. Lee, C.,&Owens, R. (2002). The psychology of men's health series.Philadelphia, PA: Open University Press.
36. Lincoln, Y. S.,&Guba, E. G. (1985). Naturalistic inquiry. Newbury Park, CA: Sage Publications.
37. Lombardi, E. (2001). Enhancing transgender health care. American Journal of Public Health, 91(6), 869-872. (Pubitemid 32496723)
38. Lucas, P. G. (2008). Regulating compassion: An overview of Canada's federal medical cannabis policy and practice. Harm Reduction Journal, 5(5). Retrieved June 15, 2009, from the World Wide Web: http://www. harmreductionjournal.com/content/5/1/5
39. Lyons, A. C. (2009). Masculinities, femininities, behaviour and health. Social and Personality Compass, 3-4, 394-412.
40. McLaren, J. A., Silins, E.,Hutchinson, D.,Mattick, R. P.,&Hall,W. (2010). Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies. International Journal of Drug Policy, 21(1), 10-19.
41. Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., et al. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370(9584), 319-328. (Pubitemid 47094993)
42. Ogborne, A. C., & Smart, R. G. (2000). Cannabis users in the general Canadian population. Substance Use & Misuse, 35, 301-311. (Pubitemid 30131934)
43. Ogborne, A. C., Smart, R. G., & Adlaf, E. M. (2000). Self-reported medical use of marijuana: A survey of the general population. Canadian Medical Association Journal, 162(12), 1685-1686. (Pubitemid 30422307)
44. Oliffe, J. L., & Phillips, M. J. (2008). Men, depression and masculinities: A review and recommendations. Journal of Men's Health, 5(3), 194-202.
45. Page, S. A., & Verhoef, M. J. (2006). Medicinal marijuana use: Experiences of people with multiple sclerosis. Canadian Family Physician, 52, 64-72.
46. Page, S. A., Verhoef, M. J., Stebbins, R. A., Metz, L. M., & Levy, J. C. (2003). Cannabis use as described by people with multiple sclerosis. Canadian Journal of Neurological Sciences, 30, 201-205. (Pubitemid 37064512)
47. Patton, D., & Adlaf, E. M. (2005). Cannabis use and problems. In E. M. Adlaf, P. Begin, & E. Sawka (Eds.), Canadian Addiction Survey (CAS): A national survey of Canadians' use of alcohol and other drugs: Prevalence of use and related harms: Detailed report. Ottawa, ON: Canadian Centre on Substance Abuse.
48. Prentiss, D., Power, R., Balmas, G., Tzuang, G., & Israelski, D. M. (2004). Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. Journal of Acquired Immune Deficiency Syndrome, 35(1), 38-45. (Pubitemid 38044780)
49. Quebec compassion club users turn to black market. (2010, June 8). CBC News. Retrieved June 15, 2010, from the World Wide Web: http://www.cbc.ca/ health/story/2010/06/08/mtl-quebecmedical-marijuana-black-market.html
50. Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(35). Retrieved June 15, 2010, from the World Wide Web: http://www.harmreductionjournal/content/6/1/35
51. Rodondi, N., Pletcher, M. J., Liu, K., Hulley, S. B., & Sidney, S. (2006).Marijuana use, diet, BMI and cardiovascular risk factors (from the CARDIA study). American Journal of Cardiology, 98, 478-484. (Pubitemid 44162873)
52. Schippers, M. (2007). Recovering the feminine other: Masculinity, femininity, and gender hegemony. Theory & Society, 36, 85-102.
53. Sherrill, D. L. (1991). Respiratory effects of non-tobacco cigarettes: A longitudinal study in the general population. International Journal of Epidemiology, 20, 132-137.
54. Smith, N. T. (2002). A review of the published literature into cannabis withdrawal symptoms in human users. Addiction, 97, 621-632. (Pubitemid 34620576)
55. Soellner, R. (2005). Dependence on cannabis-an ever-lasting issue. Substance Use and Misuse, 40, 857-867.
56. Stockwell, T., Sturge, J., Jones, W., Fischer, B., & Carter, C. (2006). Cannabis use in British Columbia: Patterns of use, perceptions, and public opinion as assessed in the 2004 Canadian Addiction Survey. Victoria, BC: Centre for Addictions Research of BC British Columbia (CARBC). Retrieved August 9, 2009, from the World Wide Web: http://carbc.ca/ portals/0/resources/ CannabisUse0609.pdf
57. Swift, W., Gates, P., & Dillon, P. (2005). Survey of Australians using cannabis for medical purposes. Harm Reduction Journal, 2, 18-28.
58. Taylor, D. R., Poulton, R., Moffitt, T. E., Ramankutty, P., & Sears, M. R. (2000). The respiratory effects of cannabis dependence in young adults. Addiction, 98, 1669-1677.
59. Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications. Archives of Internal Medicine, 167, 221-228.
60. Tjepkema,M. (2004).Use of cannabis and other illicit drugs. Health Reports, 15(4), 41-47.
61. Tramer, M. R., Carroll, D., Campbell, F., Reynolds, D. J. M., Moore, A.,&McQuay, H. J. (2001). Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. British Medical Journal, 323, 1-8.
62. Ware, M. A., Adams, H., & Guy, G. W. (2005). The medicinal use of cannabis in the UK: Results of a nationwide survey. International Journal of Clinical Practice, 59(3), 291-295. (Pubitemid 40352745)
63. Ware, M. A., Rueda, S., Singer, J., & Kilby, D. (2003). Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. Journal of Cannabis Therapeutics, 3(2), 3-15. (Pubitemid 36889409)
64. Women's Health Bureau. (2003). Exploring concepts of gender and health. Ottawa, ON: Health Canada. Retrieved February 14, 2010, from theWorldWideWeb: http://www.hc-sc.gc.ca/hlvs/ alt formats/hpb-dgps/pdf/exploring concepts.pdf
65. World Health Organisation. (2007). Gender and tobacco control: A policy brief. Geneva, Switzerland: Department of Gender, Women and Health, World Health Organization. Retrieved June 20, 2010, from the World Wide Web: http: //extranet.who.int/iris/bitstream/123456789/982/1/9789241595 773 eng.pdf
66. Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., et al. (2003). Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial. The Lancet, 362, 1517-1526. (Pubitemid 37410189)